Home › Free Stock Grades › AXGN
AxoGen, Inc. (AXGN) Stock Grade
AXGN · Healthcare
C
Market Cap
$2.3B
P/E Ratio
—
Revenue Growth (YoY)
+20.2%
Net Margin
-7.0%
Return on Equity
—
Dividend Yield
None
About AxoGen, Inc.'s fundamentals
AxoGen is a medical device company with a market capitalization of $2.3 billion that is experiencing solid revenue growth of 20.2% year-over-year. However, the company is currently unprofitable, operating with a net margin of -7.0% and reporting a net loss in its latest annual statement. The company does not pay a dividend, which is typical for growth-stage healthcare device manufacturers that are reinvesting cash into operations. While the strong revenue growth suggests market demand for its products, profitability remains a key metric to monitor going forward.